Impact of Depleting Therapeutic Monoclonal Antibodies on the Host Adaptive Immunity: A Bonus or a Malus?
Mots clés
adaptive immunity antibody-induced immunogenic cell death CD20 hematologic malignancies immunotherapy therapeutic monoclonal antibodies vaccinal effect
adaptive immunity
antibody-induced immunogenic cell death
CD20
hematologic malignancies
immunotherapy
therapeutic monoclonal antibodies
vaccinal effect
Domaines
Sciences du Vivant [q-bio]
Origine : Fichiers produits par l'(les) auteur(s)